Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
When Topicals Fail: The New IPC Consensus Every Clinician Should Know
Linda Stein Gold, MD
Bruce Strober, MD, PhD
Implementing the Latest Diagnostic and Treatment Approaches for Generalized Myasthenia Gravis
Pushpa Narayanaswami, MD, FAAN
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
RSV in Infants and Young Children: Are You Taking It Seriously Enough?
Tina Q. Tan, MD
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
All Sides of the Joint: Integrated TGCT Care Across Specialties
Taking Action Against RSV: No Child Unprotected
Yvonne Maldonado, MD
A Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
April W. Armstrong, MD, MPH
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
Joyce F. Liu, MD, MPH
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
MOA: CDH6-Targeted Antibody-Drug Conjugates
Kathleen Moore, MD, MS
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
Neelam Goyal, MD
Christyn Edmundson, MD
Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need
Naim Alkhouri, MD, FAASLD, DABOM
Evidence Base for First-Line Treatment Strategies for Endometrial Cancer and Delivering Guideline-Concordant Care
Brian Slomovitz, MD
Casey Cosgrove, MD
Michelle Flint, WHNP-BS
Evidence- and Guideline-Based Treatment for Advanced/Metastatic Cervical Cancer
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.